Anticoagulant News and Research

RSS
Study: Preoperative use of blood-thinning drugs associated with decreased risk of blood clots

Study: Preoperative use of blood-thinning drugs associated with decreased risk of blood clots

Merus reports revenues of $49.0 million for fiscal 2015

Merus reports revenues of $49.0 million for fiscal 2015

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

Older patients can recover from acute subdural hematomas

Older patients can recover from acute subdural hematomas

Columbia University data scientists create world's first catalog of therapeutic venom

Columbia University data scientists create world's first catalog of therapeutic venom

New data validates use of ActiveCare DVT prophylaxis compression system following total joint replacement surgery

New data validates use of ActiveCare DVT prophylaxis compression system following total joint replacement surgery

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

Screening for asymptomatic atrial fibrillation could reduce risk of stroke, premature death

Screening for asymptomatic atrial fibrillation could reduce risk of stroke, premature death

Nanofiber hydrogel infused with snake venom may stop bleeding, protect wounds

Nanofiber hydrogel infused with snake venom may stop bleeding, protect wounds

The American Heart Association and Heart Rhythm Society Unite to Improve Cardiovascular Research, Care

The American Heart Association and Heart Rhythm Society Unite to Improve Cardiovascular Research, Care

Pacemakers can detect AF and enable initiation of anticoagulation for stroke prevention

Pacemakers can detect AF and enable initiation of anticoagulation for stroke prevention

FDA grants accelerated approval to Praxbind (idarucizumab)

FDA grants accelerated approval to Praxbind (idarucizumab)

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

Anti-coagulant medications quickly resolve blood clots that could impair valve motion

Anti-coagulant medications quickly resolve blood clots that could impair valve motion

Acute Cardiovascular Care 2015 to be held in Vienna from 17 to 19 October

Acute Cardiovascular Care 2015 to be held in Vienna from 17 to 19 October

Boca Raton Regional Hospital introduces ultra-minimally invasive procedure for patients with atrial fibrillation

Boca Raton Regional Hospital introduces ultra-minimally invasive procedure for patients with atrial fibrillation

AF patients treated with rivaroxaban for stroke prevention experience low rates of bleeding and stroke

AF patients treated with rivaroxaban for stroke prevention experience low rates of bleeding and stroke

SLU scientist receives grant to solve blood-clotting mysteries

SLU scientist receives grant to solve blood-clotting mysteries

GARFIELD-AF Registry: All-cause death is most frequent major event in newly diagnosed AF patients

GARFIELD-AF Registry: All-cause death is most frequent major event in newly diagnosed AF patients

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.